<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00725673</url>
  </required_header>
  <id_info>
    <org_study_id>M07-1752</org_study_id>
    <secondary_id>18223</secondary_id>
    <nct_id>NCT00725673</nct_id>
  </id_info>
  <brief_title>Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.</brief_title>
  <official_title>Determination of Risk Factors for Developing Osteoporosis in COPD GOLD II Patients. A Case Control Study to Identify Possible Risk Factors for Developing Osteoporosis in COPD GOLD II Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catharina Ziekenhuis Eindhoven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catharina Ziekenhuis Eindhoven</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with COPD have been found to have an increased risk of osteoporosis. The underlying
      mechanism is not clear yet. This case control study aims to identify risk factors for
      osteoporosis in GOLD II COPD patients. COPD GOLD II patients with osteoporosis (cases) will
      be matched by gender and age to COPD GOLD II patients without osteoporosis(controls).

      Possible risk factors for osteoporosis are:

        -  BMI/VVMI (body composition)

        -  emphysema vs chronic bronchitis

        -  physical capacity

        -  Use of certain medication (eg corticosteroids, SSRI's)

        -  Nutritional status

        -  Infectious parameters Outpatients from the pulmonary ward of the Catharina Hospital
           Eindhoven with GOLD II COPD according to the ATS and GOLD-guidelines will be included in
           the study (after written informed consent).

      A DEXA-scan will be made, if patients are osteoporotic or have a normal BMD they will be
      included in the study.

      A HRCT will be made, a six minutes walking distance will be performed, blood will be drawn
      for lab. analysis, an X-ray of the vertebral collum will be made, impedance will be measured
      and hight and weight will be measuered. Also patients will fill in a questionaire.

      By univariate and multivariate analysis the collected data will be analysed to determine
      possible risk factors for th development of osteoporosis in COPD GOLD II patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk factors for osteoporosis in GOLD II COPD patients</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">106</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>GOLD II COPD patients with osteoporosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>GOLD II COPD patients with a normal bone mineral density</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        GOLD II COPD patients (ATS and GOLD guidelines) visiting the outpatient clinic of pulmonary
        medicine of the Catharina Hospital Eindhoven.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;= 40 years

          -  GOLD II COPD

          -  Written permission

        Exclusion Criteria:

          -  Age &lt; 40 years

          -  No COPD or COPD GOLD I, III or IV

          -  no written permission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lidwien Graat-Verboom</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catharina Ziekenhuis Eindhoven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Catharina Hospital Eindhoven</name>
      <address>
        <city>Eindhoven</city>
        <state>Noord-Brabant</state>
        <zip>5623 EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2008</study_first_submitted>
  <study_first_submitted_qc>July 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2008</study_first_posted>
  <last_update_submitted>November 9, 2009</last_update_submitted>
  <last_update_submitted_qc>November 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>L. Graat-Verboom/drs</name_title>
    <organization>Catharina Hospital Eindhoven</organization>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Osteoporosis</keyword>
  <keyword>BMD</keyword>
  <keyword>DEXA-scan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

